| Drug Type Interferons, Biosimilar | 
| Synonyms 因特芬 | 
| Target | 
| Action agonists, modulators, inducers | 
| Mechanism IFNAR agonists(Interferon alpha/beta receptor agonists), Immunomodulators, Innate antiviral immune response inducers | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhaseApproved | 
| First Approval Date China (01 Jan 1997),  | 
| Regulation- | 

| KEGG | Wiki | ATC | Drug Bank | 
|---|---|---|---|
| - | - | - | 
| Indication | Country/Location | Organization | Date | 
|---|---|---|---|
| Neoplasms | China  | 01 Jan 1997 | |
| Virus Diseases | China  | 01 Jan 1997 | 






